Literature DB >> 30982173

One-Year Observation of the SCID-Repopulating Cell Activities of Human Cord Blood-Derived CD34-Positive and -Negative Hematopoietic Stem Cells.

Yoshikazu Matsuoka1, Keisuke Sumide1, Yoshiaki Sonoda2.   

Abstract

Entities:  

Year:  2019        PMID： 30982173     DOI： 10.1007/s12015-019-09884-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   5.739


× No keyword cloud information.
  5 in total

1.  SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.

Authors:  Jianfeng Wang; Takafumi Kimura; Rumiko Asada; Sachio Harada; Shouhei Yokota; Yoshio Kawamoto; Yoshihiro Fujimura; Takashi Tsuji; Susumu Ikehara; Yoshiaki Sonoda
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

Review 2.  Hematopoiesis: a human perspective.

Authors:  Sergei Doulatov; Faiyaz Notta; Elisa Laurenti; John E Dick
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 3.  Normal and leukemic human stem cells assayed in SCID mice.

Authors:  J E Dick
Journal:  Semin Immunol       Date:  1996-08       Impact factor: 11.130

4.  Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis.

Authors:  Satoru Watanabe; Shinrai Ohta; Misako Yajima; Kazuo Terashima; Mamoru Ito; Hideo Mugishima; Shigeyoshi Fujiwara; Kazufumi Shimizu; Mitsuo Honda; Norio Shimizu; Naoki Yamamoto
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

5.  A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.

Authors:  Keisuke Sumide; Yoshikazu Matsuoka; Hiroshi Kawamura; Ryusuke Nakatsuka; Tatsuya Fujioka; Hiroaki Asano; Yoshihiro Takihara; Yoshiaki Sonoda
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.